Supplemental Schedule of Noncash Financing Activities (Details) - USD ($) $ in Thousands		12 Months Ended
	May. 04, 2012	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Jan. 27, 2014
Other Significant Noncash Transactions [Line Items]
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested, Shares		69,068
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested, Value		$ 2,202	$ 41	$ 1,681
Common Stock Repurchase not settled, Shares		25,000
Capitalized Software Development Costs for Software Sold to Customers		$ 3,800
Common Stock Repurchase not settled, Value		820
Derivative Liability		4,277	$ 5,367	$ 14,420
Curepet, Inc.
Other Significant Noncash Transactions [Line Items]
Purchase Price of Business Acquisition, Cost of Acquired Entity					$ 6,350
Derivative Liability		$ 0			5,000
Cash consideration offset against open receivable balances due to Ebix, Inc. from CurePet					$ 1,350
Cost Method Investment, Ownership Percentage	19.80%
Payments to acquire cost method investment	$ 2,000